Francis X. Burch

2.5k total citations · 2 hit papers
15 papers, 1.9k citations indexed

About

Francis X. Burch is a scholar working on Rheumatology, Pharmacology and Physiology. According to data from OpenAlex, Francis X. Burch has authored 15 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 6 papers in Pharmacology and 4 papers in Physiology. Recurrent topics in Francis X. Burch's work include Rheumatoid Arthritis Research and Therapies (6 papers), Inflammatory mediators and NSAID effects (5 papers) and Osteoarthritis Treatment and Mechanisms (5 papers). Francis X. Burch is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (6 papers), Inflammatory mediators and NSAID effects (5 papers) and Osteoarthritis Treatment and Mechanisms (5 papers). Francis X. Burch collaborates with scholars based in United States, Canada and Australia. Francis X. Burch's co-authors include Alan Kivitz, Stanley Cohen, John T. Sharp, Philip J. Mease, David Salonen, Evan Siegel, P A Ory, Joel Rubenstein, Wayne Tsuji and W. Bensen and has published in prestigious journals such as The American Journal of Medicine, Osteoarthritis and Cartilage and Lara D. Veeken.

In The Last Decade

Francis X. Burch

15 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression

2004 697 citations Philip J. Mease, Alan Kivitz et al. Arthritis & Rheumatism profile →
Intraarticular injection of anakinra in osteoarthritis of the knee: A multicenter, randomized, double‐blind, placebo‐controlled study

2009 414 citations Xavier Chevalier, Philippe Goupille et al. Arthritis Care & Research profile →

Peers

Countries citing papers authored by Francis X. Burch

Since Specialization

Citations

This map shows the geographic impact of Francis X. Burch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francis X. Burch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francis X. Burch more than expected).

Fields of papers citing papers by Francis X. Burch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francis X. Burch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francis X. Burch. The network helps show where Francis X. Burch may publish in the future.

Co-authorship network of co-authors of Francis X. Burch

This figure shows the co-authorship network connecting the top 25 collaborators of Francis X. Burch. A scholar is included among the top collaborators of Francis X. Burch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francis X. Burch. Francis X. Burch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee 2011 ·Arthritis Research & Therapy ·Stanley Cohen, Susanna Proudman, Alan Kivitz, Francis X. Burch, John P. Donohue, Deborah Burstein, Yu‐Nien Sun, Christopher Banfield, Michael S. Vincent, Liyun Ni, Debra Zack	197
2	A phase 2 randomized, double-blind study of AMG 108, a fully human monoclonal antibody to IL-1R, in patients with rheumatoid arthritis 2010 ·Arthritis Research & Therapy ·Mario H. Cardiel, Paul P. Tak, W. Bensen, Francis X. Burch, Šárka Forejtová, J Badurski, Tarundeep Kakkar, (unknown), Liyun Ni, (unknown), Angelika Jahreis, Debra Zack	21
3	Intraarticular injection of anakinra in osteoarthritis of the knee: A multicenter, randomized, double‐blind, placebo‐controlled study breakdown → 2009 ·Arthritis Care & Research ·Xavier Chevalier, Philippe Goupille, A. D. Beaulieu, Francis X. Burch, W. Bensen, Thierry Conrozier, Damien Lœuille, Alan Kivitz, David Silver, Brent E. Appleton	414
4	Evaluating the benefits of patterned stimulation in the treatment of osteoarthritis of the knee 2008 ·Osteoarthritis and Cartilage ·Francis X. Burch, (unknown), (unknown), (unknown)	48
5	A Comparison of the Analgesic Efficacy of Tramadol Contramid OAD Versus Placebo in Patients with Pain Due to Osteoarthritis 2007 ·Journal of Pain and Symptom Management ·Francis X. Burch, (unknown), (unknown), Bruce Corser, (unknown), (unknown), (unknown), (unknown), André Beaulieu, (unknown), (unknown), (unknown), (unknown), (unknown), Sylvie Bouchard	46
6	A placebo-controlled, randomized, double-blinded study evaluating the safety of etanercept in patients with rheumatoid arthritis and concomitant comorbid diseases 2007 ·Lara D. Veeken ·Michael H. Weisman, Harold E. Paulus, Francis X. Burch, Alan Kivitz, Joshua Fierer, M. Dunn, David Kerr, (unknown), Scott W. Baumgartner	52
7	Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept. 2006 ·PubMed ·Philip J. Mease, Alan Kivitz, Francis X. Burch, Evan Siegel, Stanley Cohen, P A Ory, David Salonen, Joel Rubenstein, John T. Sharp, M. Dunn, Wayne Tsuji	167
8	Lidocaine patch 5% improves pain, stiffness, and physical function in osteoarthritis pain patients 2004 ·Osteoarthritis and Cartilage ·Francis X. Burch, C. Codding, Nachiket Patel, Eric Sheldon	66
9	Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression breakdown → 2004 ·Arthritis & Rheumatism ·Philip J. Mease, Alan Kivitz, Francis X. Burch, Evan Siegel, Stanley Cohen, P A Ory, David Salonen, Joel Rubenstein, John T. Sharp, Wayne Tsuji	697
10	Topical lidocaine patch 5% may target a novel underlying pain mechanism in osteoarthritis 2004 ·Current Medical Research and Opinion ·Bradley S. Galer, Eric Sheldon, Nileshkumar Patel, (unknown), Francis X. Burch, Arnold R. Gammaitoni	47
11	Long-term treatment of rheumatoid arthritis comparing nabumetone with aspirin 1987 ·The American Journal of Medicine ·(unknown), Daniel J. Appelrouth, Arthur D. Bankhurst, Joseph J. Biundo, Barry Bockow, (unknown), (unknown), Francis X. Burch, Rowland W. Chang, Mark H. Cohen, M. Eric Gershwin, J. Timothy Harrington, (unknown), (unknown), Robert P. Searles, Fredrica E. Smith	15
12	Six-month multi-center study comparing nabumetone with naproxen in the treatment of osteoarthritis 1987 ·The American Journal of Medicine ·Edward J. Pisko, Barry Bockow, (unknown), (unknown), Francis X. Burch, Ronald L. Collins, Roy Fleischmann, (unknown), (unknown), Jeffrey E. Poiley, Sanford H. Roth, Robert P. Searles, Riccardo Senter	19
13	Treatment of ankylosing spondylitis with oxaprozin: A comparison with indomethacin 1986 ·Seminars in Arthritis and Rheumatism ·Jacques R. Caldwell, Roy D. Altman, Francis X. Burch, Andrei Călin	8
14	Evaluation of the safety of isoxicam 1985 ·The American Journal of Medicine ·Francis X. Burch	2
15	A hypocomplementemic vasculitic urticarial syndrome 1980 ·The American Journal of Medicine ·C. Raymond Zeiss, Francis X. Burch, Robert J. Marder, Nancy Furey, Frank R. Schmid, H Gewurz	97

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact